Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Premenopausal Breast Cancer”

161 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 161 results

Large-scale testing (Phase 3)Study completedNCT00049452
What this trial is testing

Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer

Who this might be right for
Breast CancerOsteoporosis
Herbert Irving Comprehensive Cancer Center 120
Not applicableStudy completedNCT03505736
What this trial is testing

Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+18 more
Wake Forest University Health Sciences 25
Large-scale testing (Phase 3)Looking for participantsNCT02535221
What this trial is testing

Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer

Who this might be right for
Breast Cancer
Peking University 234
Large-scale testing (Phase 3)UnknownNCT04753177
What this trial is testing

The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

Who this might be right for
The Neoadjuvant Therapy
Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary 120
Not applicableStudy completedNCT07127315
What this trial is testing

Assessing Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy

Who this might be right for
Gonadotropin Releasing Hormone AgonistsOvarian FunctionPremenopausal+2 more
Helwan University 100
Not applicableUnknownNCT03383835
What this trial is testing

Study of Moderate Dose Omega 3 Fatty Acid Supplement in Premenopausal Women at High Risk for Breast Cancer

Who this might be right for
Breast Cancer
Lauren Nye 11
Testing effectiveness (Phase 2)Study completedNCT00019500
What this trial is testing

Raloxifene in Preventing Breast Cancer in Premenopausal Women

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Not applicableUnknownNCT03582865
What this trial is testing

Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen

Who this might be right for
Breast Cancer
Assiut University 100
Not applicableStudy completedNCT00975676
What this trial is testing

Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 123
Not applicableStudy completedNCT00118508
What this trial is testing

The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)

Who this might be right for
Osteoporosis
University of Pittsburgh 87
Large-scale testing (Phase 3)Study completedNCT06009627
What this trial is testing

Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 119
Large-scale testing (Phase 3)Study completedNCT01546649
What this trial is testing

Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast Cancer

Who this might be right for
Premenopausal Breast Cancer
Takeda 167
Testing effectiveness (Phase 2)Study completedNCT00056082
What this trial is testing

Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women

Who this might be right for
Breast Cancer
University of Kansas Medical Center 110
Early research (Phase 1)Study completedNCT00976339
What this trial is testing

Study of Vitamin D for Premenopausal Women at High Risk for Breast Cancer

Who this might be right for
Breast Cancer
Katherine D. Crew 20
Testing effectiveness (Phase 2)Study completedNCT03628066
What this trial is testing

Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 24
Not applicableActive Not RecruitingNCT03448003
What this trial is testing

Comprehensive Lifestyle Change To Prevent Breast Cancer

Who this might be right for
Premenopausal
M.D. Anderson Cancer Center 60
Not applicableLooking for participantsNCT00823654
What this trial is testing

Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 609
Not applicableLooking for participantsNCT06273800
What this trial is testing

Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 100
Testing effectiveness (Phase 2)Ended earlyNCT00090844
What this trial is testing

Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer

Who this might be right for
Breast CancerHormone ChangesDrug Toxicity
University of South Florida 49
Not applicableStudy completedNCT02154139
What this trial is testing

Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"

Who this might be right for
Breast Cancer
Takeda 651
Load More Results